
After nearly 4 years of deliberation, FDA punts on how to regulate CBD
The FDA is giving up on trying to figure out a way to regulate CBD on its own, and formally calling on Congress for help.
Read The StoryTracking how politics and policy influence health care and medicine. To get the latest delivered to your inbox, sign up for our free D.C. Diagnosis newsletter. And subscribe to STAT+ for inside intelligence on the intersection of Capitol Hill and the life sciences.
The FDA is giving up on trying to figure out a way to regulate CBD on its own, and formally calling on Congress for help.
Read The Story